Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466679016 | Mitozantrone 25mg/12.5mL infusion | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1457161019 | Mitozantrone 2mg/mL injection concentrate 12.5mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1477689018 | Mitozantrone 2mg/mL injection concentrate 12.5mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Is a | Product containing mitoxantrone (medicinal product) | false | Inferred relationship | Some | ||
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Has active ingredient | Mitoxantrone (substance) | false | Inferred relationship | Some | ||
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Has active ingredient | Anthracycline (substance) | false | Inferred relationship | Some | ||
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Mitozantrone 2mg/mL injection concentrate 12.5mL vial | Has manufactured dose form | Injection concentrate | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR